CPP phase 2 clinical trial
Ended Awarded Last action
- Contract number
- 0001
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755 Part of General Dynamics Corp
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,685,156
Award facts
- Opportunity
-
- W81XWH13R0038 Solicitation number
- Medical Product Research and Development (MPRD) Indefinite Delivery Indefinite Quantity Contract Award Notice · Posted Jun 5, 2013
- Contract value 100% obligated
- $1,685,156.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$73 | |
| Other Administrative Action | -$76 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$485,012 | |
| Change Order | -$350,000 | |
| Funding Only Action | $500,000 | |
| Funding Only Action | $1,000,000 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,020,318 | |
| Other Administrative Action | -$520,318 | |
| Original award | $520,318 |
Show all 11
About this award
This is a cost-plus-fixed-fee delivery order awarded by the Medical Command (MEDCOM) of the U.S. Army to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation. The $1,685,156.08 contract is for the Phase 2 clinical trial of the Comprehensive Preventive and Preparedness (CPP) program, which develops medical countermeasures for infectious diseases. The contract is part of Dynport's existing $30 million Preclinical Services for Biopharmaceutical Product Development indefinite delivery, indefinite quantity (IDIQ) contract with the National Institute of Allergy and Infectious Diseases (NIAID). This award does not have a set-aside designation.
Quick answers
Who was awarded contract 0001?
0001 was awarded to Dynport Vaccine Company LLC by Medical Command (Department of the Army) on November 1, 2016.
How much is contract 0001 worth?
The government has obligated $1,685,156 on 0001.
Is contract 0001 an order under another contract?
Yes. 0001 is a delivery order under W81XWH15D0037, an indefinite delivery contract, on Medical Product Research and Development.
Was contract 0001 competed?
The extent of competition for 0001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award